Lowering the cut point for impaired fasting glucose: where is the evidence? Where is the logic?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed.

1. Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population.Frontiers in endocrinology · 2023
   Article
2. Utility of ALT Concentration in Men and Women with Nonalcoholic Fatty Liver Disease: Cohort Study.Journal of clinical medicine · 2019
   Article
3. Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia.Nutrients · 2017 · on this map
   Review
4. Examination of the fasting and 2-h plasma glucose in the light of impairment in beta-cell function: what does the epidemiological data tell us?Endocrine · 2015
   Article
5. Fitness, fatness, and survival in adults with prediabetes.Diabetes care · 2014
   Article
6. A prospective study of fasting plasma glucose and risk of stroke in asymptomatic men.Mayo Clinic proceedings · 2011
   Article
7. Nitric oxide synthase 3 deficiency limits adverse ventricular remodeling after pressure overload in insulin resistance.American journal of physiology. Heart and circulatory physiology · 2011
   Article
8. Normal fasting plasma glucose and risk of prediabetes and type 2 diabetes: the Isfahan Diabetes Prevention Study.The review of diabetic studies : RDS · 2011
   Article
9. Predicting prediabetes and diabetes: can we do it? Is it worth it?Archives of pediatrics & adolescent medicine · 2010
   Article
10. Mild fasting hyperglycemia in children: high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus.Pediatric diabetes · 2009
    Article
11. Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose.The Journal of clinical endocrinology and metabolism · 2009
    Article
12. Prevalence of cardiometabolic risk factors by weight status in a population-based sample of Quebec children and adolescents.The Canadian journal of cardiology · 2008
    Article
13. The effect of lowering the threshold for diagnosis of impaired fasting glucose.Yonsei medical journal · 2008
    Article
14. New Zealand cardiovascular guidelines: best practice evidence-based guideline: the assessment and management of cardiovascular risk December 2003.The Clinical biochemist. Reviews · 2007
    Article
15. Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart.Heart (British Cardiac Society) · 2007
    Article
16. Comment on: Godsland IF, Jeffs JAR, Johnston DG (2004) Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47:1157-1166.Diabetologia · 2005
    Article
17. [Validity of the diagnostic tests for diabetes].Atencion primaria · 2004
    Article

Corrections and comments

• Comment on
  Follow-up report on the diagnosis of diabetes mellitus.2003

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as